³Ô¹ÏÍøÕ¾

Latest biotechnology News | Page 5

Australian researchers develop a donor stem cell therapy for the successful treatment of osteoarthritis
Orthocell moves ahead on global market expansion with seven new regulatory applications
AI Partnership Takes Step In Ryght Direction
Telix completes significant raise that could be used for acquisitions
Remembering Nobel Laureate Professor Robin Warren AC
Neuren secures Rare Paediatric Disease Designation from FDA
Chimeric Therapeutics says first patient enrolled in cell therapy trial
Noxopharm Says Several Companies Evaluating Its Assets
Minister to speak at Australian Space Forum
The long – and strange – history of testing menstrual blood for health conditions
New Perth Based RNA Facility To Improve Cancer Outcomes
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
Burnet senior research officer awarded Moderna Global Fellowship
Queensland-based De Motu Cordis progresses development of innovative anaphylaxis treatment
Views sought in ³Ô¹ÏÍøÕ¾ Health and Medical Research Workforce Audit
Scientists make breakthrough in development of fridge-free storage for vital medicines
Merck expands its fertility benefit to employees in New Zealand
Immutep reports positive results from trial of combination cancer therapy
Dimerix Awarded Bioshares Excellence Award
New Funding Announced For Diabetes Technology Research
New Medicines Manufacturing Innovation Centre, co-located at the Australian Synchrotron, opened
Hub Opens Opportunities For New Disease Treatments
Orthocell receives regulatory approval to commence sales of Striate+ in Canada
Telix welcomes CMS proposal to improve payment for specialised diagnostic radiopharmaceuticals
Nominations sought for new shared MRFF and NHMRC advisory committees
Orthocell Reports Record Quarterly And Yearly Revenue
Genetic Technologies’ GeneType to enter Canadian and New Zealand markets
Dr James Campbell Appointed AusBiotech Chair
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
Dimerix says the recruitment of adolescent patients to commence in Phase 3 trial
Top Performing ASX Companies
A-UKFTA Inaugural Joint Committee Meeting – statement
BioMelbourne Network board strengthened with five new appointments
Actinogen’s phase 2a depression trial completes final patient visit
First CEO for the Sydney-based Viral Vector Manufacturing Facility
TeraPore uses Cornell research to address virus filtration challenges
Actinogen Medical says positive Xanamem phase 2a biomarker trial published in key Journal
Immutep reports topline results from TACTI-003 Phase 2b trial
Funding available for dementia and cognitive decline innovations through CUREator+
Members Sought For New Policy Taskforce
Psylo partnership to deliver psychedelic treatments for mental health
Gardening linked to staying sharp in later life, study finds
ARC Invests In Research Partnerships With Industry
Beyond CRISPR: seekRNA delivers a new pathway for accurate gene editing
Imugene doses the first patient in pioneering Phase 1 onCARlytics tria
Immutep signs exclusive license agreement with Cardiff University for anti-LAG-3 molecules
State Government Budget Wrap For Life Sciences
La Trobe Receives $11 Million In ARC Funding